In HCC, EpCAM has been considered as an important CSC marker and is an active target of Wnt/ β-catenin signaling (Yamashita et al., 2007; Yamashita et al., 2009; Yamashita et al., 2013). Here, EPCAM is linked to hepatocellular carcinoma.